Big drug data for big drug trials: development, validation, and implementation of routinely-collected data on medications within large trials in cardiovascular disease and COVID-19... door Pessoa-Amorim, G

Making trials part of good clinical care: lessons from the RECOVERY trial door Pessoa-Amorim, G, Campbell, M, Fletcher, L, Horby, P, Landray, M, Mafham, M, Haynes, R

Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK Biobank door Camm, CF, Von Ende, A, Gajendragadkar, PR, Pessoa-Amorim, G, Mafham, M, Allen, N, Parish, S, Casadei, B, Hopewell, JC

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial door Mafham, M, Haynes, R, Landray, M, Horby, P, Pessoa-Amorim, G, Staplin, N, Emberson, J, Spata, E, Campbell, M, Peto, L

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial door Landray, M, Horby, P, Mafham, M, Peto, L, Campbell, M, Pessoa-Amorim, G, Spata, E, Staplin, N, Emberson, J, Haynes, R

Left atrial 4D flow cardiovascular magnetic resonance: a reproducibility study in sinus rhythm and atrial fibrillation door Spartera, M, Pessoa-Amorim, G, Stracquadanio, A, Von Ende, A, Fletcher, A, Manley, P, Neubauer, S, Ferreira, VM, Casadei, B, Hess, AT, Wijesurendra, RS

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, p... door Horby, PW, Emberson, JR, Basnyat, B, Campbell, M, Peto, L, Pessoa-Amorim, G, Staplin, N, Hamers, RL, Mafham, M, Haynes, R, Landray, M

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial door Horby, P, Peto, LW, Staplin, N, Campbell, M, Pessoa-Amorim, G, Mafham, M, Emberson, J, Day, J, Knight, M, Thwaites, G, Haynes, R, Landray, M

Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology door Pessoa-Amorim, G, Camm, CF, Gajendragadkar, P, De Maria, GL, Arsac, C, Laroche, C, Zamorano, JL, Weidinger, F, Achenbach, S, Maggioni, AP, Gale, CP, Poppas, A, Casadei, B

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis door RECOVERY Collaborative Group, Horby, P, Emberson, J, Mafham, M, Peto, L, Campbell, M, Pessoa-Amorim, G, Spata, E, Staplin, N, Day, J, Juszczak, E, Knight, M, Haynes, R, Landray, M

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial door Abani, O, Abbas, A, Abbas, F, Staplin, N, Peto, L, Emberson, JR, Campbell, M, Pessoa-Amorim, G, Thwaites, L, Van Doorn, R, Horby, P, Knight, M, Thwaites, G, Mafham, M, Haynes, R, Landray, M

Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospita... door Pessoa-Amorim, G, Goldacre, R, Crichton, C, Stevens, W, Nunn, M, King, A, Murray, D, Welsh, R, Pinches, H, Rees, A, Morris, EJA, Landray, MJ, Haynes, R, Horby, P, Wallendszus, K, Peto, L, Campbell, M, Harper, C, Mafham, M

Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospita... door Pessoa-Amorim, G, Goldacre, R, Crichton, C, Stevens, W, Nunn, M, King, A, Murray, D, Welsh, R, Pinches, H, Rees, A, Morris, EJV, Landray, M, Haynes, R, Horby, P, Wallendszus, K, Peto, L, Campbell, M, Harper, C, Mafham, M

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis door RECOVERY Collaborative Group, Horby, P, Emberson, J, Mafham, M, Campbell, M, Peto, L, Pessoa-Amorim, G, Spata, E, Staplin, N, Lowe, C, Chadwick, D, Brightling, C, Stewart, R, Collini, P, Ashish, A, Green, C, Prudon, B, Felton, T, Kerry, A, Baillie, K, Buch, M, Day, JN, Faust, S, Jaki, T, Jeffery, K, Juszczak, E, Knight, M, Lim, WS, Montgomery, A, Mumford, A, Rowan, K, Thwaites, G, Haynes, R, Landray, M

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial door RECOVERY Collaborative Group, Horby, P, Pessoa-Amorim, G, Staplin, N, Emberson, J, Campbell, M, Spata, E, Peto, L, Brunskill, N, Tiberi, S, Chew, V, Brown, T, Tahir, H, Ebert, B, Chadwick, D, Whitehouse, T, Sarkar, R, Graham, C, Baillie, K, Basnyat, B, Buch, M, Chappell, L, Day, J, Faust, S, Hamers, R, Jaki, T, Juszczak, E, Jeffery, K, Lim, WS, Montgomery, A, Mumford, A, Rowan, K, Thwaites, G, Mafham, M, Haynes, R, Landray, M

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial door Horby, PW, Campbell, M, Spata, E, Emberson, JR, Staplin, N, Pessoa-Amorim, G, Peto, L, Wiselka, M, Wiffen, L, Tiberi, S, Caplin, B, Wroe, C, Green, C, Hine, P, Prudon, B, George, T, Wight, A, Baillie, JK, Basnyat, B, Buch, MH, Chappell, LC, Day, JN, Faust, SN, Hamers, RL, Jaki, T, Juszczak, E, Jeffery, K, Lim, WS, Montgomery, A, Mumford, A, Rowan, K, Thwaites, G, Mafham, M, Haynes, R, Landray, MJ

Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial door RECOVERY Collaborative Group, Horby, PW, Staplin, N, Peto, L, Emberson, JR, Campbell, M, Pessoa-Amorim, G, Basnyat, B, Thwaites, L, Van Doorn, R, Hamers, RL, Nel, J, Amuasi, J, Stewart, R, Ghosh, D, Hamilton, F, Desai, P, Easom, N, Majumdar, J, Hine, P, Chadwick, D, Cooke, G, Sharp, S, Esmail, H, Baillie, JK, Buch, MH, Faust, SN, Jaki, T, Jeffery, K, Juszczak, E, Knight, M, Lim, WS, Montgomery, A, Mukherjee, A, Mumford, A, Rowan, K, Thwaites, G, Mafham, M, Haynes, R, Landray, MJ